GS
Genfit S.A.
🇬🇧XLON.0QT6United KingdomHealthcare
€12.14EURup +0.47 (+4.03%)ClosedEnd of day6:54 PM
Price€12.14+0.47 (+4.03%)
Profile
- Healthcare
- Biotechnology
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- Not reported
- CUSIP
- Not reported
Company
- Employees
- 188
- Headquarters
- Loos, United States
- Website
- https://www.genfit.com
- CEO
- Mr. M. Pascal Prigent
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- €0.17
- P/E LTM
- 21.05
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- €92.45M+203.69%up year on year
- Net income
- €10.21M+119.92%up year on year
- Gross margin
- 110.11%-1.62%down year on year
- Free cash flow
- -€88.85M-12.33%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.